Johnson & Johnson's Growing Drug Dependency Makes The Business More Unpredictable

Johnson & Johnson's Growing Drug Dependency Makes The Business More Unpredictable


J&J's strong Pharma performance over the past few years, coupled with tepid growth in Consumer Healthcare and Medical Devices, indicates a shift in basic revenue structure. The more they succeed at Pharma and lose growth in Consumer Healthcare, the greater their risk of unstable revenue growth.



from Biotech News